• Most Popular
  • Most Shared

Biogen, PDL BioPharma say daclizumab trial meets main goal

Mon Mar 12, 2007 7:27am EDT

Stocks

   

Regulatory News

March 12 (Reuters) - Biogen Idec Inc. (BIIB.O) and PDL BioPharma Inc. (PDLI.O) said the ongoing mid-stage trial of daclizumab, a humanized monoclonal antibody, met its main goal in relapsing multiple sclerosis .

In a statement, the companies said the anti-IL-2 receptor antibody significantly reduced the number of new or enlarged lesions compared to the dummy drug.

The companies plan to initiate a mid-stage monotherapy trial of daclizumab.

(Reporting by Deepti Chaudhary in Bangalore)

((Editing by Anil D'Silva; Reuters Messaging: deepti.chaudhary.reuters@reuters.net: within U.S. +1 646 223 8780; outside U.S. +91 80 4135 5800)) Keywords: BIOGEN TRIAL/

(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nWNAS3666



More from Reuters

Photo

Obama says U.S. will pursue plane attackers

KAILUA, Hawaii (Reuters) - A wing of al Qaeda claimed responsibility on Monday for a failed Christmas Day attack on a U.S.-bound passenger plane and President Barack Obama vowed to bring "every element" of U.S. power against those who threaten Americans' safety. | Video

Passengers queue to go through security checks at the departure gate at Gatwick Airport, in southern England December 28, 2009.    REUTERS/Luke MacGregor

Travel headaches after scare

The U.S. is stepping up airline security measures following the Christmas bomb scare. Here's what you can expect.  Full Article | Video 

Iranian protesters take a policeman away to a safe place after he was beaten by angry protesters during fierce clashes in central Tehran December 27, 2009. Credit: REUTERS/Stringer

Deaths, arrests in Iran

Is Iran's "iron fist of brutality" a new volatile phase aimed at crushing the refomist movement?  Full Article | Video